Global Biobetters Market
Global Biobetters Market Analysis to 2034 by Drug Class, Disease Indication, Route of Administration, Distribution Channel, and Region, Featuring Exhaustive Profiles of the Top 10+ Players
09 avr. 2024 11h54 HE | Research and Markets
Dublin, April 09, 2024 (GLOBE NEWSWIRE) -- The "Global Biobetters Market by Drug Class, by Disease Indication, by Route of Administration, by Distribution Channel, and By Region" report has been...
US Pharmaceutical Market
US Pharmaceutical Market Review 2020-2023 and Forecast 2024-2030: A $1.28 Trillion Opportunity, Driven by the Rising Adoption of AI-based Tools for Drug Discovery
27 mars 2024 08h34 HE | Research and Markets
Dublin, March 27, 2024 (GLOBE NEWSWIRE) -- The "US Pharmaceutical Market Size and Forecast (2020 - 2030), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product...
22157.jpg
Aflibercept (Eylea) Biosimilars Pipeline Review 2024: Patents are Due to Run out from 2023 to 2032
23 févr. 2024 07h32 HE | Research and Markets
Dublin, Feb. 23, 2024 (GLOBE NEWSWIRE) -- The "Aflibercept (Eylea) Biosimilars Pipeline Review" report has been added to ResearchAndMarkets.com's offering.This product provides basic information on...
22157.jpg
Eculizumab (Soliris) Biosimilars & Biosuperiors Pipeline Review 2024
23 févr. 2024 07h31 HE | Research and Markets
Dublin, Feb. 23, 2024 (GLOBE NEWSWIRE) -- The "Eculizumab (Soliris) Biosimilars & Biosuperiors Pipeline Review" report has been added to ResearchAndMarkets.com's offering.This product provides...
22157.jpg
Biosimilar Interleukins ( IL-17, IL-23, IL-1, IL-5, IL-6 ) Global Market Report 2024 - Robust CAGR of 40% Predicted by 2028
13 févr. 2024 11h46 HE | Research and Markets
Dublin, Feb. 13, 2024 (GLOBE NEWSWIRE) -- The "Biosimilar Interleukins Global Market Report 2024" has been added to ResearchAndMarkets.com's offering. The latest comprehensive research on the...
Global Biosimilars and Biologics Market
Global Biosimilars and Biologics Market Surges: $46.11 Billion Market Forecast for 2028 - Industry Trends and Strategic Analysis
02 févr. 2024 10h43 HE | Research and Markets
Dublin, Feb. 02, 2024 (GLOBE NEWSWIRE) -- The "Global Biosimilars and Biologics Market (2023-2028) by Product, Application, and Geography, Competitive Analysis, Impact of Covid-19, Ansoff Analysis"...
22157.jpg
Biosimilars Market Poised for Substantial Growth by 2031, Driven by Rising Chronic Disease Prevalence
29 janv. 2024 12h36 HE | Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Biosimilars Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user,...
22157.jpg
Biosimilar Insulin Market Global Industry Analysis - Market Set to Surge, Spearheaded by High Demand in APAC and Cost-Effective Innovations
29 janv. 2024 12h24 HE | Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Biosimilar Insulin Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application,...
22157.jpg
Biosimilars in Oncology - Pricing is a Key Issue for Biosimilars Entering an Increasingly Crowded Market
23 janv. 2024 10h38 HE | Research and Markets
Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "Thematic Intelligence - Biosimilars in oncology" report has been added to ResearchAndMarkets.com's offering.The report provides an insight into the...
22157.jpg
Omalizumab (Xolair) Biosimilars & Biosuperiors Pipeline Review 2023
14 déc. 2023 05h48 HE | Research and Markets
Dublin, Dec. 14, 2023 (GLOBE NEWSWIRE) -- The "Omalizumab (Xolair) Biosimilars & Biosuperiors Pipeline Review" report has been added to ResearchAndMarkets.com's offering.This product provides...